BridgeMD
New treatment option for HIV
Official title HomeLink2: Reducing Posthospitalization Mortality Through Structured Home Care and Nutritional Support
ClinicalTrials.gov ID: NCT07102745
What this study is testing
- What it's testing
- People living with HIV (PLWH) are at high risk of poor health outcomes after being discharged from the hospital. This study is designed to test whether providing structured care at home-either with or without nutritional support-can help reduce the risk of death within six months of discharge and improve long-term health outcomes.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Documented HIV infection (either diagnosed during or prior to hospital admission), consisting of any clinical documentation, including a chart note...
- ≥18 years old as per hospital file or government issued document
- Self-report that the participant resides within Matlosana sub-district
- Admitted to an adult internal medicine ward at Tshepong Hospital
- Have spent at least 2 nights in the hospital prior to recruitment to the trial.
You likely can't join if
- Admitted to a non-medical (i.e., surgical, psychiatric, etc.) ward, admitted for elective reasons, or admitted to facilitate onward transfer to...
- Participant or next of kin unable to provide written informed consent in any of the languages of the informed consents or spoken by the study team
See the full eligibility criteria
- Documented HIV infection (either diagnosed during or prior to hospital admission), consisting of any clinical documentation, including a chart note of HIV positivity, Ritonavir-boosted darunavir (RVD) positivity, or...
- ≥18 years old as per hospital file or government issued document
- Self-report that the participant resides within Matlosana sub-district
- Admitted to an adult internal medicine ward at Tshepong Hospital
- Have spent at least 2 nights in the hospital prior to recruitment to the trial.
- Agree to post-discharge follow-up, including home visits
- Are able to provide informed consent or if lacking capacity to provide consent at the time of recruitment, as determined by the study team, have a next of kin able to provide informed consent.
- Admitted to a non-medical (i.e., surgical, psychiatric, etc.) ward, admitted for elective reasons, or admitted to facilitate onward transfer to another hospital
- Participant or next of kin unable to provide written informed consent in any of the languages of the informed consents or spoken by the study team
The study team makes the final eligibility decision.
Where it's taking place
- Klerksdorp, North West, South Africa
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Klerksdorp, North West, South Africa. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.